KRAS is a molecular determinant of platinum responsiveness in glioblastoma. Zuchegna C, Leone S, Romano A, Porcellini A, et al. BMC Cancer 2024;24:77.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zuchegna C, Leone S, Romano A, Porcellini A, et al. KRAS is a molecular determinant of platinum responsiveness in glioblastoma. BMC Cancer 2024;24:77.
PMID: 38225605